Trio Medicines
Develops medicines for pharmaceutical and biotechnology partners, including candidates for unmet medical needs
Highlights
- New on EvolcAdded 2026-11-03
About Trio Medicines
Trio Medicines develops pharmaceutical candidates, including netazepide and ceclazepide, gastrin/CCK2 receptor antagonists, as well as TR4 and TR8.
The company seeks partners for further clinical studies. Its parent company, Hammersmith Medicines Research, has funded and conducted Trio’s early clinical trials.
Trio was founded in 2007 and is based at its parent company’s premises in London, UK. Its registered headquarters are in Worthing, UK.
Product: Develops pharmaceutical candidates including netazepide, ceclazepide, TR4 and TR8.
Jobs at Trio Medicines
Leadership
- Jim Black · FounderSource: company website
- Malcolm Boyce · Medical Director, HMRSource: company website
More biotech & pharma companies
UFRACTION8
Scalable microfluidic cell-separation systems for bio-manufacturers processing cell culturesNew on EvolcUK Biocentre
Biological sample storage, processing and shipping for biomedical research, pharma and biotech teams in the UKNew on EvolcUsv UK
UK pharmaceutical subsidiary supplying and distributing medicines, including its own-label products, to the UK marketNew on EvolcValid Insight
Market access consultancy helping pharma, biotech and medtech companies with payer strategy, pricing and launch evidenceNew on EvolcValneva UK
Develops and supplies travel vaccines and clinic support for healthcare providersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- LiteSpeedHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.